{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:05:13Z","timestamp":1783688713434,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81871018"],"award-info":[{"award-number":["81871018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.eplepsyres.2020.106353","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:06:57Z","timestamp":1589155617000},"page":"106353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Predictors of drug-resistance in epilepsy with auditory features"],"prefix":"10.1016","volume":"164","author":[{"given":"Lin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjiao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangmiao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2020.106353_bib0005","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/epi.13086","article-title":"Recurrent secondary generalization in frontal lobe epilepsy: predictors and a potential link to surgical outcome?","volume":"56","author":"Baud","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0010","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/epi.14033","article-title":"Epilepsy with auditory features: long-term outcome and predictors of terminal remission","volume":"59","author":"Bisulli","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0020","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/01.WNL.0000063324.39980.4A","article-title":"Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features","volume":"60","author":"Fertig","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"Suppl 5","key":"10.1016\/j.eplepsyres.2020.106353_bib0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1528-1167.2006.00881.x","article-title":"Lateralizing value of the auditory aura in partial seizures","volume":"47","author":"Florindo","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0040","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.0013-9580.2004.09704.x","article-title":"Semiologic and electrophysiologic correlations in temporal lobe seizure subtypes","volume":"45","author":"Maillard","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0045","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0050","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.seizure.2013.02.002","article-title":"Early predictors of outcome in newly diagnosed epilepsy","volume":"22","author":"Mohanraj","year":"2013","journal-title":"Seizure"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0055","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"12","author":"Nevitt","year":"2017","journal-title":"Cochr. Database Syst. Rev."},{"issue":"Pt 6","key":"10.1016\/j.eplepsyres.2020.106353_bib0060","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1093\/brain\/123.6.1247","article-title":"Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families","volume":"123","author":"Picard","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0065","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000005","article-title":"Epilepsy with auditory features A heterogeneous clinico-molecular disease","volume":"1","author":"Pippucci","year":"2015","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0070","doi-asserted-by":"crossref","first-page":"17800","DOI":"10.1523\/JNEUROSCI.6121-11.2012","article-title":"Glutamate receptor 1 phosphorylation at serine 831 and 845 modulates seizure susceptibility and hippocampal hyperexcitability after early life seizures","volume":"32","author":"Rakhade","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2020.106353_bib0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.seizure.2018.12.023","article-title":"Factors predicting uncontrolled seizures in epilepsy with auditory features","volume":"65","author":"Zhang","year":"2019","journal-title":"Seizure"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120300759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121120300759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:43:38Z","timestamp":1760276618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121120300759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":15,"alternative-id":["S0920121120300759"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106353","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of drug-resistance in epilepsy with auditory features","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106353"}}